Cohort of Peripheral T Cell Lymphoma
NCT02364466 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2015-02-18
Summary
Prospective, observational cohort study of peripheral T cell lymphoma. Purpose is to investigate the complication including febrile neutropenia in the era of pegylated G-CSF prophylaxis.
Conditions
- Lymphoma, T-Cell, Peripheral
- Febrile Neutropenia
Sponsors & Collaborators
-
Samsung Medical Center
collaborator OTHER -
Asan Medical Center
collaborator OTHER -
Keimyung University Dongsan Medical Center
collaborator OTHER -
Kosin University Gospel Hospital
collaborator OTHER -
Dankook University
collaborator OTHER -
Soonchunhyang University Hospital
collaborator OTHER -
Ajou University School of Medicine
collaborator OTHER -
Yeungnam University Hospital
collaborator OTHER -
Ulsan University Hospital
collaborator OTHER -
Inje University
collaborator OTHER -
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
collaborator OTHER -
Hallym University Medical Center
collaborator OTHER -
Hanyang University Seoul Hospital
collaborator OTHER -
Seoul National University Hospital
collaborator OTHER -
Pusan National University Hospital
collaborator OTHER -
National Health Insurance Service Ilsan Hospital
collaborator OTHER -
Hanyang University
collaborator OTHER -
Korea Cancer Center Hospital
lead OTHER
Principal Investigators
-
Won Seog Kim, M.D., Ph.D. · Samsung Medical Center
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Circulating Tumor DNA in Peripheral T-cell Lymphomas
NCT06362148 ·Status: ACTIVE_NOT_RECRUITING
-
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL
NCT02445404 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma
NCT04489264 ·Status: RECRUITING
-
Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma
NCT04338282 ·Status: UNKNOWN ·Phase: PHASE2
-
Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
NCT02474550 ·Status: UNKNOWN
-
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
NCT05821192 ·Status: UNKNOWN ·Phase: NA
-
Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma
NCT02221492 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL
NCT03465527 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
NCT05377307 ·Status: RECRUITING
-
CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma
NCT03542266 ·Status: COMPLETED ·Phase: PHASE2
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT04922567 ·Status: RECRUITING ·Phase: PHASE2
-
Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
NCT05075460 ·Status: RECRUITING ·Phase: PHASE3
-
Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
NCT03283111 ·Status: UNKNOWN ·Phase: NA
-
γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
NCT04028440 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
NCT00725231 ·Status: UNKNOWN ·Phase: PHASE3
-
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
NCT06422247 ·Status: COMPLETED
-
International Extranodal NK/T-cell Lymphoma Project
NCT02386813 ·Status: COMPLETED
-
AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)
NCT06511869 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients
NCT04696705 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
NCT07253129 ·Status: RECRUITING
-
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma
NCT07300514 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients
NCT03870412 ·Status: UNKNOWN ·Phase: NA
-
the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma
NCT05834751 ·Status: UNKNOWN ·Phase: NA
-
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
NCT01202448 ·Status: COMPLETED ·Phase: NA